Phebra NZ Limited is a subsidiary of Phebra, an Australian owned company that supplies and manufactures high quality and innovative pharmaceuticals.

Critical medicines are manufactured across a range of therapeutic areas including antidotes, anti-infectives, emergency cardiovascular, respiratory, central nervous system, diagnostic dyes, infusion solutions, oncology, pain and other specialised products.

Phebra’s manufacturing plant in Sydney is licensed by Australia’s Therapeutic Goods Administration, is compliant to current Good Manufacturing Practices, and is an FDA accredited sterile manufacturing facility.